Roger Moore

Roger Moore has 40 years experience in the international pharmaceutical industry, including almost 30 years as President of Novo Nordisk Japan (Novo Nordisk is the world's largest manufacturer of insulin and a global leader in diabetes care). Mr Moore established Novo's organisation in Japan as the first employee in 1977, and worked for the company until his retirement as Chairman at the end of 2007. From 2000, Roger Moore was appointed Senior Vice President, Japan and Oceania Region, responsible for Novo Nordisk's business in Japan, Australia, New Zealand and the Pacific. He was also appointed a member of the Senior Management Board, Novo Nordisk A/S. In 2007 Mr Moore was awarded the Knight's Cross of the Order of the Dannebrog by Queen Margrethe II of Denmark.
Bio last updated 21 Dec 2016

Access to our data for Roger Moore is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Roger Moore is linked to 1 organisation which is included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 28/09/18

1 year TSR5 year TSR
301stProteomics International Laboratories18%0%
516thTransaction Solutions International-14%-0%
739 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Non-Executive Director
Year started and most recent title


129th↑Transaction Solutions International$2.3m
130th↓Proteomics International Laboratories$2.1m
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer